MedTrace Logo

A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Intense Strong

NCT06562075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2026-03-27

No results posted yet for this study

Summary

A post-market Follow up clinical investigation to confirm the clinical safety and performance profile of Decoria®Intense Strong for the correction and improvement of jawline profile.

Conditions

  • Jawline Contour Deficit

Interventions

DEVICE

Decoria Intense Strong

Decoria® Intense Strong is a HA-based, BDDE-crosslinked dermal filler. Decoria® Intense Strong dermal fillers are injected into dermal tissue to improve and define contouring of jawline profile, supporting overlying tissue to shape facial contours to desired level of correction. Appropriate injection volume for the jawline will be determined by the Treating investigator according to IFU

Sponsors & Collaborators

  • Key2Compliance

    collaborator INDUSTRY

  • Bohus Biotech AB

    lead INDUSTRY

Principal Investigators

  • Lucian Grema, M.D · Florakliniken, Stockholm, Sweden

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-06
Primary Completion
2025-12-12
Completion
2025-12-25

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06562075 on ClinicalTrials.gov